Management of Hepatitis C Infection

  • Authors: Jordan J. Feld, MD, MPH; Hemant Shah, MD, MScCH HPTE (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 7/24/18 (What's New)

Summary

  • Viral and host factors influence likelihood of response to interferon-based therapy (Table 40) (Table 41)[Sarrazin 2010]
    • Viral Factors
    • Responses to approved interferon-based therapies are greatest with genotype 2, followed by genotype 3, genotype 4, and then genotype 1
    • High baseline HCV RNA is associated with poorer response to interferon-based therapies
    Host Factors

    Action required

    Keywords: Hepatitis C-Treatment

    ©2018 Clinical Care Options, LLC. All Rights Reserved.

    The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.